CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,000 | +115.5% | 952,343 | +208.4% | 0.03% | +22.2% |
Q4 2022 | $1,856 | -99.5% | 308,813 | +281.6% | 0.03% | +440.0% |
Q1 2022 | $378,000 | -31.4% | 80,916 | -57.3% | 0.01% | -37.5% |
Q1 2021 | $551,000 | -27.4% | 189,516 | -19.6% | 0.01% | +14.3% |
Q4 2020 | $759,000 | – | 235,817 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,904,400 | $3,355,000 | 2.31% |
BVF INC/IL | 6,929,690 | $5,955,000 | 0.65% |
CAXTON CORP | 324,452 | $279,000 | 0.32% |
NEA Management Company, LLC | 3,750,000 | $3,222,000 | 0.23% |
Orbimed Advisors | 5,000,000 | $4,297,000 | 0.07% |
Fosun International Ltd | 459,274 | $390,000 | 0.03% |
Paloma Partners Management Co | 229,800 | $197,000 | 0.00% |
OXFORD ASSET MANAGEMENT LLP | 127,602 | $110,000 | 0.00% |
LMR Partners LLP | 54,931 | $47,000 | 0.00% |
Tower Research Capital LLC (TRC) | 17,495 | $15,000 | 0.00% |